These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 8164837)
21. Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Joniec I; Ciesielska A; Kurkowska-Jastrzebska I; Przybylkowski A; Czlonkowska A; Czlonkowski A Brain Res; 2009 Mar; 1261():7-19. PubMed ID: 19401171 [TBL] [Abstract][Full Text] [Related]
22. Chronic L-deprenyl does not alter the restoration of striatal dopamine in MPTP-lesioned mice. Wiener HL; Hashim A; Lajtha A; Sershen H J Neurosci Res; 1989 Jul; 23(3):326-9. PubMed ID: 2504936 [TBL] [Abstract][Full Text] [Related]
23. GM1 ganglioside rescues substantia nigra pars compacta neurons and increases dopamine synthesis in residual nigrostriatal dopaminergic neurons in MPTP-treated mice. Schneider JS; Kean A; DiStefano L J Neurosci Res; 1995 Sep; 42(1):117-23. PubMed ID: 8531220 [TBL] [Abstract][Full Text] [Related]
24. [Therapeutic effect of a natural squamosamide derivative FLZ on Parkinson's disease model mice induced by LPS plus MPTP]. Yu LH; Wei HL; Bao XQ; Zhang D; Sun H Yao Xue Xue Bao; 2013 Oct; 48(10):1557-62. PubMed ID: 24417082 [TBL] [Abstract][Full Text] [Related]
25. Administration of GM1 ganglioside eliminates neuroleptic-induced sensorimotor deficits in MPTP-treated mice. Weihmuller FB; Hadjiconstantinou M; Bruno JP; Neff NH Neurosci Lett; 1988 Oct; 92(2):207-12. PubMed ID: 2903475 [TBL] [Abstract][Full Text] [Related]
26. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice. D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368 [TBL] [Abstract][Full Text] [Related]
27. Assessment of the role of multidrug resistance-associated proteins in MPTP neurotoxicity in mice. Plangár I; Zádori D; Szalárdy L; Vécsei L; Klivényi P Ideggyogy Sz; 2013 Nov; 66(11-12):407-14. PubMed ID: 24555241 [TBL] [Abstract][Full Text] [Related]
28. Persistent depletion of striatal dopamine in mice by m-hydroxy-MPTP. Fuller RW; Hemrick-Luecke SK Res Commun Chem Pathol Pharmacol; 1986 Aug; 53(2):167-72. PubMed ID: 3764080 [TBL] [Abstract][Full Text] [Related]
29. Amine fluorescence histochemical investigation of the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced parkinsonian mice. Mizukawa K; Ogawa N; Sora YH Res Commun Chem Pathol Pharmacol; 1988 Jan; 59(1):121-8. PubMed ID: 3258432 [TBL] [Abstract][Full Text] [Related]
30. Persistent depletion of striatal dopamine in mice by 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine (MTTP). Fuller RW; Robertson DW; Hemrick-Luecke SK Biochem Pharmacol; 1986 Jan; 35(2):143-4. PubMed ID: 3484628 [No Abstract] [Full Text] [Related]
31. Amantadine enhances dopamine and serotonin turnover in the MPTP model of Parkinson's disease. Altagracia M; Rojas P; Kravzov J; Rios C Proc West Pharmacol Soc; 1993; 36():289-91. PubMed ID: 7690973 [No Abstract] [Full Text] [Related]
32. Ganglioside derivative LIGA20 reduces NMDA neurotoxicity in neonatal rat brain. Lipartiti M; Lazzaro A; Manev H Neuroreport; 1992 Oct; 3(10):919-21. PubMed ID: 1421099 [TBL] [Abstract][Full Text] [Related]
33. Riluzole and experimental parkinsonism: antagonism of MPTP-induced decrease in central dopamine levels in mice. Boireau A; Dubédat P; Bordier F; Peny C; Miquet JM; Durand G; Meunier M; Doble A Neuroreport; 1994 Dec; 5(18):2657-60. PubMed ID: 7696626 [TBL] [Abstract][Full Text] [Related]
34. Characterization of hepatic microsomal metabolism as an in vivo detoxication pathway of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Chiba K; Kubota E; Miyakawa T; Kato Y; Ishizaki T J Pharmacol Exp Ther; 1988 Sep; 246(3):1108-15. PubMed ID: 3262153 [TBL] [Abstract][Full Text] [Related]
35. Selenium partially reverses the depletion of striatal dopamine and its metabolites in MPTP-treated C57BL mice. Khan HA Neurochem Int; 2010 Nov; 57(5):489-91. PubMed ID: 20619308 [TBL] [Abstract][Full Text] [Related]
36. GM1 ganglioside protects against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse. Janson AM; Agnati LF; Fuxe K; Cintra A; Sundstrom E; Zini I; Toffano G; Goldstein M Acta Physiol Scand; 1988 Apr; 132(4):587-8. PubMed ID: 3265839 [No Abstract] [Full Text] [Related]
37. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction]. Nishi K; Kondo T; Narabayashi H No To Shinkei; 1987 Jul; 39(7):663-72. PubMed ID: 3314916 [TBL] [Abstract][Full Text] [Related]
38. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice. Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274 [TBL] [Abstract][Full Text] [Related]
39. Partially protective effect of amantadine in the MPTP model of Parkinson's disease. Rojas P; Altagracia M; Kravsov J; Rios C Proc West Pharmacol Soc; 1992; 35():33-5. PubMed ID: 1502234 [No Abstract] [Full Text] [Related]
40. Differential recovery of sensorimotor function in GM1 ganglioside-treated vs. spontaneously recovered MPTP-treated cats: partial striatal dopaminergic reinnervation vs. neurochemical compensation. Schneider JS; Schroeder JA; Rothblat DS Brain Res; 1998 Nov; 813(1):82-7. PubMed ID: 9824674 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]